by Brooks | Jan 8, 2025 | Emerging Trends, Reduce Adverse Drug Reactions
Jayden Lee, PharmD & Zachary S. Brooks, PhD A New Way to Get Medications: Next Generation Sequencing for You. How do you currently get your medications? You see a doctor who diagnoses you, then receive a prescription. Your pharmacist performs a second check to...
by Brooks | Dec 30, 2024 | Emerging Trends, Mental Health and Psychiatry
Jayden Lee, EMBA, PharmD, BCACP & Husna Rahim, PharmD Pharmacogenomics: Effective and reliable Clinical Trials for Depression. With mental health taking center stage post-COVID-19 pandemic, what are some new ways to improve the treatment of depression? One...
by Brooks | Dec 30, 2024 | Emerging Trends, Reduce Adverse Drug Reactions
Jayden Lee, EMBA, PharmD, BCACP & Husna Rahim, PharmD The Transformative Potential of Phenoconversion in Pharmacogenomics. What is phenoconversion, and why is it pivotal in the realm of pharmacogenomics (PGx)? An exploration of phenoconversion, PGx mechanisms, and...
by Brooks | Dec 29, 2024 | Cardiology, Emerging Trends
Husna Rahim, PharmD & Jennifer Tovar, PharmD Pharmacogenomics in Cardiovascular Diseases – Making Your Treatment Better. What is the current role of precision medicine in treating cardiovascular diseases (CVDs)? The rapidly evolving field of pharmacology and...
by Brooks | Dec 29, 2024 | Emerging Trends, Reduce Adverse Drug Reactions
Husna Rahim, PharmD & Kate Choy-Kay Lee Exploring Genetic Variations in Drug Metabolism. How do genetic variations influence drug metabolism and patient response to therapy? Genetic variations, also known as polymorphisms, can significantly affect how an...
by Brooks | Dec 29, 2024 | Emerging Trends, Mental Health and Psychiatry
Husna Rahim, PharmD & Kate Choy-Kay Lee Pharmacogenomics in Mental Health: A Look at Schizophrenia. How can pharmacogenomics (PGx) be leveraged to optimize treatments for patients suffering from mental illness? In contrast to diseases of physical manifestation,...
